Levothyroxine: Therapeutic use and regulatory issues related to bioequivalence

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 6, 2002, Pages 727-732

  Wartofsky, Leonard ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Bioequivalence; Hypothyroidism; Levothyroxine; Thyroid; Thyroid hormone

Indexed keywords

GENERIC DRUG; LEVO T; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; THYROTROPIN; THYROXINE; UNITHROID;

BIOEQUIVALENCE; CONTROLLED STUDY; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG LABELING; DRUG MARKETING; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; FOOD AND DRUG ADMINISTRATION; GOITER; HUMAN; HYPOTHYROIDISM; PATHOPHYSIOLOGY; REVIEW; STANDARD; SYMPTOMATOLOGY; THYROID NODULE; THYROTROPIN BLOOD LEVEL; ARTICLE; BIOAVAILABILITY; LEGAL ASPECT; METABOLISM; PHARMACOKINETICS;

BIOLOGICAL AVAILABILITY; DRUG APPROVAL; HUMANS; HYPOTHYROIDISM; THERAPEUTIC EQUIVALENCY; THYROXINE;

EID: 0036072916     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.6.727     Document Type: Review

References (13)

1. The case for more aggressive screening and treatment of mild thyroid failure
2. Treatment guidelines for patients with hyperthyroidism and hypothyroidism
3. Thyroxine therapy
4. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism
5. Levothyroxine therapy in patients with thyroid disease
6. The use and misuse of thyroid hormone
7. Thyroid hormone therapy: What, when and how much
8. The equivalency of two 1-thyroxine preparations
9. Bioequivalence of generic and brand levothyroxine products in the treatment of hypothyroidism
10. Bioequivalence of levothyroxine preparations: Shortcomings and implications of a recently published study
11. Bioequivalence of levothyroxine preparations: Shortcomings and implications of a recently published study
12. Towards a practical strategy for assessing individual bioequivalence. (FDA Working Panel)